Innovative Wound Care: Maggot Therapy for Diabetic Foot Ulcers

Maggot Debridement Therapy for the Treatment of Diabetic Foot Ulcers: Prevention of Amputations in Diabetic Foot Infections

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/083862

Enrollment

Registered

2025-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Maggot Debridement Therapy: After giving standard of care, the diabetic foot ulcers will be treated with maggots debridement therapy. Intervention includes both standard of care and ma

Eligibility

Inclusion criteria

Inclusion criteria: Individuals with Diabetic Foot ulcers Evidence of infection confirmed with microbiology culture report ability and willingness to provide written informed consent

Exclusion criteria

Exclusion criteria: Individuals with peripheral arterial disease Those infected with HIV, Hepatitis B&C Individuals who are Pregnant/ Lactating Unwilling to provide written informed consent

Design outcomes

Primary

Measure	Time frame
Complete wound healing/skin closureTimepoint: 120 days	—

Secondary

Measure	Time frame
improvement in quality of lifeTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Vijay Viswanathan

Department of Diabetology, M V Hospital for Diabetes and Prof M Viswanathan Diabetes Research Centre

drvijay@mvdiabetes.com914425954913

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026